Jeena Sikho Lifecare secures NABH accreditation for Raipur hospital

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Jeena Sikho Lifecare received NABH accreditation for its Raipur hospital
  • Certification covers Panchakarma services under certificate AH-2026-0513
  • Accreditation is valid until August 20, 2029
  • Development occurred in the ordinary course of business without capacity expansion
powered bylight_fuzz_icon
52411215

*this image is generated using AI for illustrative purposes only.

Jeena Sikho Lifecare Limited has received accreditation from the National Accreditation Board for Hospitals & Healthcare Providers (NABH) for its hospital in Raipur, Chhattisgarh. The certification covers Panchakarma services and remains valid until August 20, 2029.

Details of the accreditation

The company informed stock exchanges that the accreditation was granted for its facility located at IVA Complex, Near Saraswati Nagar Railway Station, Kota Main Road, Raipur. The specific certificate number issued is AH-2026-0513.

Location Services Accredited Certificate No. Valid Till
Raipur, Chhattisgarh Panchakarma AH-2026-0513 August 20, 2029

Compliance and operational context

The intimation was filed under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company stated that this development occurred in the ordinary course of business. It does not constitute business expansion, capacity enhancement, or acquisition.

NABH accreditation signifies adherence to nationally recognized standards for quality healthcare delivery, patient safety, and operational excellence. This recognition reinforces the company's commitment to standardized Ayurvedic care protocols across its network.

Historical Stock Returns for Jeena Sikho Lifecare

1 Day5 Days1 Month6 Months1 Year5 Years
+1.02%-19.89%-23.80%-41.25%-50.11%+1,899.74%

How will the NABH accreditation impact Jeena Sikho Lifecare's ability to secure insurance partnerships and third-party payer agreements for its Panchakarma services?

Does this certification signal a broader strategic shift toward standardizing clinical protocols across the company's entire hospital network to prepare for potential future expansions?

What specific operational cost increases or revenue uplifts are projected from maintaining NABH compliance standards until the 2029 expiry date?

Jeena Sikho shareholders approve ₹4.50 dividend; all resolutions pass

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • All 15 resolutions at Jeena Sikho Lifecare's 9th AGM passed with requisite majorities
  • Final dividend of ₹4.50 per share for FY26 approved by shareholders
  • Promoter group voted unanimously in favour of all resolutions
  • Institutional investors opposed several special resolutions, including Section 185 approvals
powered bylight_fuzz_icon
52146498

*this image is generated using AI for illustrative purposes only.

Jeena Sikho Lifecare Limited shareholders approved a final dividend of ₹4.50 per equity share for the financial year ended March 31, 2026, during the company's 9th Annual General Meeting (AGM). The voting results, submitted to stock exchanges on September 30, 2026, confirm that all 15 resolutions passed with requisite majorities.

The meeting was held on Monday, September 28, 2026, at the company's venue in Zirakpur, Punjab. In addition to the dividend payout, members adopted both the audited standalone and consolidated financial statements for FY26, along with the reports of the Board of Directors and Statutory Auditors. The scrutinizer’s report dated September 29, 2026, verified the e-voting and poll results.

Board reappointments and new directorships

The AGM addressed several key governance matters involving the board composition. Mrs. Bhavna Grover was reappointed as Director by rotation and also as Whole-time Director and Key Managerial Personnel through separate resolutions. Mr. Manish Grover was reappointed as Managing Director and Key Managerial Personnel via a special resolution.

Mr. Karan Vir Bindra was reappointed as an Independent Director. The meeting also saw the appointment of new directors to strengthen the board's expertise:

  • Mr. Ajay Sharma appointed as Non-Executive Independent Director
  • Mrs. Sapna Singh appointed as Non-Executive Woman Independent Director
  • Dr. Ish Sharma appointed as Director and Whole-time Director
  • Mr. Ankush Kaushal appointed as Director and Whole-time Director

Voting outcomes and shareholder participation

A total of 46,817 shareholders were on record as of September 21, 2026. Voting took place via remote e-voting from September 25 to September 27, 2026, and through a poll at the AGM venue. The promoter group held 79,080,648 shares, while public institutions held 6,557,924 shares, and public non-institutions held 38,662,158 shares.

The following table summarizes the voting results for key resolutions:

Resolution Item Type Votes in Favour Votes Against Result
Adopt Standalone FS FY26 Ordinary 7,97,60,033 389 Approved
Adopt Consolidated FS FY26 Ordinary 7,97,60,033 389 Approved
Final Dividend ₹4.50/share Ordinary 7,97,60,033 389 Approved
Reappoint Bhavna Grover (Director) Ordinary 7,97,60,032 390 Approved
Reappoint Karan Vir Bindra (Ind. Dir) Special 7,96,42,153 1,18,269 Approved
Appoint Ajay Sharma (Non-Exec Ind.) Special 7,97,60,033 389 Approved
Appoint Sapna Singh (Woman Ind. Dir) Special 7,95,81,986 1,78,436 Approved
Approve Sec 185 Loans/Guarantees Special 7,94,64,019 2,96,353 Approved

Financial approvals and operational mandates

Members granted specific powers to the Board regarding financial transactions under the Companies Act, 2013. This included approval to grant loans, give guarantees, or provide security to persons covered under Section 185. Additionally, approval was sought for granting loans, giving guarantees or securities, and making investments under Section 186. Both these special resolutions passed with over 99% of votes in favour, despite notable opposition from institutional investors.

Meeting proceedings and compliance

Ms. Priya Goyal, Company Secretary and Compliance Officer, facilitated the electronic voting process supervised by M/s Rawal & Co, Practising Company Secretaries, who served as the Scrutinizer. The remote e-voting facility was active from September 25 to September 27, 2026. The Chairman noted that the Statutory Auditors' Report contained no qualifications or observations requiring member attention, except as otherwise stated. Voting results were announced within two working days of the meeting's conclusion.

Historical Stock Returns for Jeena Sikho Lifecare

1 Day5 Days1 Month6 Months1 Year5 Years
+1.02%-19.89%-23.80%-41.25%-50.11%+1,899.74%

How will the appointment of two new Whole-time Directors, Dr. Ish Sharma and Mr. Ankush Kaushal, influence Jeena Sikho Lifecare's strategic direction in the healthcare sector?

What specific growth initiatives or capital expenditures are planned to justify the Board's newly granted powers under Section 186 for investments and guarantees?

Given the notable opposition from institutional investors on Section 185 and 186 resolutions, what measures will the management take to address governance concerns and restore investor confidence?

More News on Jeena Sikho Lifecare

1 Year Returns:-50.11%